GOVX · GeoVax Labs, Inc.
$0.72
-0.04 (-4.79%)
At close · Jul 28
Going-concern doubt
— flagged Jul 27, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors collectively raise substantial doubt about the Company's ability to continue as a going concern. Management believes that we will be successful in securing the additional capital required to continue the Company's planned operations, but that our plans do not fully alleviate the substantial doubt about the Company's ability to operate as a going concern.”View the 10-Q filed Jul 27, 2026
Market Cap
$2.64M
Shares
7.37M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.76
Open$0.78
Day$0.74–0.80
52W$0.69–20.65
Avg vol 30d459K
Short int150K · 2.0% float · 1.0d
Short vol54%
Last earningsNov 13, 2025
DataSep 2020–Jul 2026
Filing10-Q · Jul 27
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 27, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.66
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−83%
below
Price vs 50-day avg
−49%
below
RSI (14)
31
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−42%
trailing
6-month return
−73%
trailing
YTD return
−82%
this year
Relative strength
−80%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
2 of 16 funds reported for Jun 30 · net +2.2K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.04% of float · ▲ +139.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
16 holders — 13F breadth
Squeeze score
46
elevated · 0–100
Fundamentals
Revenue growth
−37%
Y/Y
Free cash flow
$-21.5M
Balance sheet
$3.1M
net cash
Quant / Vol
risk profile
Volatility
141%
annualized · 1-yr
Max drawdown
−96%
past year
ATR
19.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−83%
Bearish
Price vs 50-day avg
−49%
Bearish
RSI (14)
31
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
2 of 16 funds reported for Jun 30 · net +2.2K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.04% of float · ▲ +139.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
16 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $1
Now $1 · 0%
52-wk high $21
vs 200-day avg -83%
vs 50-day avg -49%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GOVX
this stock
GeoVax Labs, Inc.
|
$2.64M | -82.2% | -37.1% | — | 2.0% |
|
ONC
BeOne Medicines Ltd.
|
$471.01B | +7.3% | +22179.2% | 958.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.57B | +5.7% | +46.2% | 28.4 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.95B | -13.5% | +20.8% | 16.3 | 3.3% |
|
ARGX
Argenx SE
|
$55.61B | +5.7% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GOVX | -22.9% | -42.4% | -72.9% | -40.2% | -82.2% |
| SPY | -0.6% | +0.7% | +6.8% | -1.0% | +8.4% |
| vs SPY | -22.3% | -43.1% | -79.7% | -39.1% | -90.6% |